Literature DB >> 8194657

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

S I Taylor1, D Accili, Y Imai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8194657     DOI： 10.2337/diab.43.6.735

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  49 in total

1.  Turning down insulin signaling.

Authors:  M J Birnbaum
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans.

Authors:  C Xiao; A Giacca; A Carpentier; G F Lewis
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

4.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Authors:  Yasuo Terauchi; Iseki Takamoto; Naoto Kubota; Junji Matsui; Ryo Suzuki; Kajuro Komeda; Akemi Hara; Yukiyasu Toyoda; Ichitomo Miwa; Shinichi Aizawa; Shuichi Tsutsumi; Yoshiharu Tsubamoto; Shinji Hashimoto; Kazuhiro Eto; Akinobu Nakamura; Mitsuhiko Noda; Kazuyuki Tobe; Hiroyuki Aburatani; Ryozo Nagai; Takashi Kadowaki
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Authors:  Pascale Perret; Lotfi Slimani; Arnaud Briat; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

6.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Genetic manipulation of insulin action and beta-cell function in mice.

Authors:  B Lamothe; B Duvillié; N Cordonnier; A Baudry; S Saint-Just; D Bucchini; J Jami; R L Joshi
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

8.  American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice.

Authors:  J T Xie; C Z Wang; M Ni; J A Wu; S R Mehendale; H H Aung; A Foo; C S Yuan
Journal:  J Food Sci       Date:  2007-10       Impact factor: 3.167

9.  Possible domains responsible for intracellular targeting and insulin-dependent translocation of glucose transporter type 4.

Authors:  K Ishii; H Hayashi; M Todaka; S Kamohara; F Kanai; H Jinnouchi; L Wang; Y Ebina
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

10.  Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist.

Authors:  Yukiko Kanda; Masashi Shimoda; Sumiko Hamamoto; Kazuhito Tawaramoto; Fumiko Kawasaki; Mitsuru Hashiramoto; Koji Nakashima; Michihiro Matsuki; Kohei Kaku
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.